Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Rheumatology

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/rheumatology/keu350PMID 25239881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac arrhythmias and conduction defects in systemic sclerosis.

  2014cited by this paper
• Cardiac Tissue Characterization and the Diagnostic Value of Cardiovascular Magnetic Resonance in Systemic Connective Tissue Diseases

  2014cited by this paper
• Assessment of myocardial damage by cardiac MRI in patients with anorexia nervosa.

  2013cited by this paper
• The impact of repeated marathon running on cardiovascular function in the aging population

  2012cited by this paper
• Coronary artery abnormalities in CREST syndrome revealed by cardiovascular magnetic resonance imaging.

  2011cited by this paper
• Diverse Patterns of Myocardial Fibrosis in Lifelong, Veteran Endurance Athletes

  2011cited by this paper
• Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension.

  2011cited by this paper
• Detection of Myocardial Fibrosis in Systemic Sclerosis by Contrast-Enhanced Magnetic Resonance Imaging

  2008cited by this paper
• Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients

  2008cited by this paper
• Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion and Delayed Enhancement in Asymptomatic Patients with Systemic Sclerosis

  2008cited by this paper
• Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.

  2007cited by this paper
• Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography: a myocardial echostress scleroderma pattern

  2006cited by this paper
• PET abnormalities in patients with nonischemic cardiomyopathy.

  2004cited by this paper
• High prevalence of right ventricular systolic dysfunction in early systemic sclerosis.

  2004cited by this paper
• Assessment of disease severity and prognosis.

  2003cited by this paper
• The assessment of the patient with systemic sclerosis.

  2003cited by this paper
• Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

  1999cited by this paper
• Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study

  1998cited by this paper
• Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis.

  1996cited by this paper
• Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis.

  1996cited by this paper
• Cardiac involvement in systemic sclerosis.

  1992cited by this paper
• A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

  1990cited by this paper
• The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature.

  1985cited by this paper
• Study of 102 Consecutive Cases with Functional Correlations and Review of the Literature

  1985cited by this paper
• Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma.

  1984cited by this paper
• Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.

  1984cited by this paper
• The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS).

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Atrioventricular nodal function in progressive systemic sclerosis: electrophysiological and morphological findings.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• The cardiac conduction system in progressive systemic sclerosis. Clinical and pathologic features of 35 patients.

  1976cited by this paper

• Cardiac magnetic resonance in systemic sclerosis: imaging features and potential prognostic implications. A literature review

  2025cites this paper
• Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications

  2025cites this paper
• Unmasking the Hidden Threat: The Role of Left Ventricular Subendocardial Involvement in Autoimmune Rheumatic Disease

  2025cites this paper
• Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases

  2025cites this paper
• Noninvasive left ventricular myocardial work identifies subclinical myocardial dysfunction in patients with systemic sclerosis

  2025cites this paper
• Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution

  2024influential citation
• Autoimmune Disorders in Heart Failure With Preserved Ejection Fraction.

  2024cites this paper
• Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis

  2024cites this paper
• Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis.

  2024cites this paper
• Manifestations cardiaques des maladies auto-immunes et des vascularites

  2024cites this paper
• Coronary microvascular dysfunction in rheumatic diseases — what do we know today?

  2024cites this paper
• Heart involvement in systemic sclerosis: emerging concepts

  2024cites this paper
• Biomarkers in the evaluation of cardiac involvement in systemic sclerosis

  2024cites this paper
• Cardiac Involvement Due to COVID-19: Insights from Imaging and Histopathology

  2023cites this paper
• Diagnosis and management of primary heart involvement in systemic sclerosis.

  2023cites this paper
• Epicardial adipose tissue in patients with systemic sclerosis

  2023cites this paper
• Right Ventricle and Autoimmune Diseases.

  2023cites this paper
• Left Ventricular Strain in Systemic Diseases

  2023cites this paper
• The presence of abnormal septal motion on echocardiography is a predictor of abnormal cardiac magnetic resonance in systemic sclerosis.

  2023cites this paper
• Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis.

  2023cites this paper
• Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function.

  2023cites this paper
• Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis

  2023cites this paper
• Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma.

  2023cites this paper
• Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases.

  2023cites this paper
• Evaluation of hypertension in systemic sclerosis and systemic lupus erythematosus overlap

  2022cites this paper
• COVID-19: Energy, Protein Folding & Prion Disease

  2022cites this paper
• Cardiac Magnetic Resonance in Rheumatology to Detect Cardiac Involvement Since Early and Pre-clinical Stages of the Autoimmune Diseases: A Narrative Review

  2022cites this paper
• Sclerodermic Cardiomyopathy—A State-of-the-Art Review

  2022cites this paper
• Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging

  2022cites this paper
• A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension

  2022influential citation
• Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update.

  2022cites this paper
• The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review

  2022cites this paper
• Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers

  2021cites this paper
• Clinical assessment of cardiac impairment favored by two-dimensional speckle tracking echocardiology in patients with systemic sclerosis.

  2021cites this paper
• A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

  2021cites this paper
• Systemic sclerosis portends increased risk of conduction and rhythm abnormalities at diagnosis and during disease course: A US population-based cohort

  2021cites this paper
• Kardiale Beteiligungen bei rheumatologischen Erkrankungen – eine Übersicht

  2021cites this paper
• Myocardial Involvement Detected Using Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis: A Prospective Observational Study

  2021cites this paper
• Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice points.

  2021cites this paper
• CardioRheumatology

  2021cites this paper
• Heart Failure with Preserved Ejection Fraction and Cardiomyopathy: an Under-recognized Complication of Systemic Sclerosis

  2021cites this paper
• Advanced Echocardiography Techniques: The Future Stethoscope of Systemic Diseases

  2021cites this paper
• Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management

  2021cites this paper
• Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances

  2020cites this paper
• T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

  2020cites this paper
• Characterization of the inflammatory‐metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease

  2020cites this paper
• The Double-Edged Sword of T1-Mapping in Systemic Sclerosis—A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance

  2020cites this paper
• Novel Imaging Strategies in Systemic Sclerosis

  2020cites this paper
• Imaging in Chronic Lung Disease: Cardiac Considerations

  2020cites this paper
• Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.

  2020cites this paper
• Association of cardiac magnetic resonance‐detected myocardial abnormalities with disease characteristics and brain natriuretic peptide levels in systemic sclerosis without cardiac symptoms

  2019cites this paper
• Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis

  2019cites this paper
• Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases

  2019cites this paper
• Getting to the heart of the matter: detecting and managing cardiac complications in systemic sclerosis

  2019cites this paper
• Imaging for screening cardiovascular involvement in patients with systemic rheumatologic diseases: more questions than answers.

  2019cites this paper
• Cardiac autonomic modulation at rest and during orthostatic stress among different systemic sclerosis subsets.

  2019cites this paper
• Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.

  2019cites this paper
• Arrhythmia in systemic sclerosis: catheter ablation or not?

  2019cites this paper
• Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP

  2019cites this paper
• Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis

  2019cites this paper
• Defining primary systemic sclerosis heart involvement: A scoping literature review.

  2019cites this paper
• Estadios clínicos en pacientes con esclerosis sistémica en Holguín

  2018cites this paper
• Complete heart block in systemic sclerosis

  2018cites this paper
• The role of cardiovascular magnetic resonance imaging in rheumatic heart disease.

  2018cites this paper
• Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians.

  2018cites this paper
• Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis

  2018cites this paper
• Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis

  2018cites this paper
• Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study

  2018cites this paper
• Chapter 13 – Systemic Sclerosis

  2017cites this paper
• Pathology of Systemic Sclerosis

  2017cites this paper
• Cardiac Involvement: Evaluation and Management

  2017cites this paper
• Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".

  2017cites this paper
• Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis‐associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension

  2017cites this paper
• Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis

  2017cites this paper
• Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset

  2017cites this paper
• New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction

  2017cites this paper
• Scleroderma in children.

  2017cites this paper
• Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases

  2017cites this paper
• systemic sclerosis . “ Pearls and pitfalls ” Algorithm of heart disease in scleroderma

  2017cites this paper
• Recent advances in the management of juvenile systemic sclerosis

  2017cites this paper
• Non-cardiac sarcoid actually affects the heart by reducing coronary flow reserve.

  2017cites this paper
• Cardiac complications of systemic sclerosis and management: recent progress

  2017cites this paper
• The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis.

  2016cites this paper
• Pseudo-infarction pattern in diffuse systemic sclerosis. Evaluation using cardiovascular magnetic resonance.

  2016cites this paper
• Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course

  2016cites this paper
• Early cardiac involvement in asymptomatic patients with systemic sclerosis (Ssc) established using cardiac magnetic resonance (CMR)

  2016cites this paper
• Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

  2016cites this paper
• Magnetic Resonance Imaging Applications on Infiltrative Cardiomyopathies

  2016cites this paper
• Impact of myocardial fibrosis on left ventricular diastolic function in patients with systemic sclerosis

  2016cites this paper
• Bone marrow mesenchymal stromal cells with CD47 high expression via the signal transducer and activators of transcription signaling pathway preventing myocardial fibrosis.

  2015cites this paper
• Systemic sclerosis: a critical digest of the recent literature.

  2015cites this paper
• Myocardial perfusion defects and fibrosis in early systemic sclerosis (SSc) assessed using cardiac magnetic resonance (CMR)

  2015cites this paper